135 related articles for article (PubMed ID: 15717247)
41. Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community.
Farr BM; Woodhead MA; Macfarlane JT; Bartlett CL; McCraken JS; Wadsworth J; Miller DL
Respir Med; 2000 May; 94(5):422-7. PubMed ID: 10868703
[TBL] [Abstract][Full Text] [Related]
42. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
Hedlund J
Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
[TBL] [Abstract][Full Text] [Related]
43. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network.
Welte T; Köhnlein T
Semin Respir Crit Care Med; 2009 Apr; 30(2):127-35. PubMed ID: 19296412
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for community-acquired pneumonia in adults: a population-based case-control study.
Almirall J; Bolíbar I; Balanzó X; González CA
Eur Respir J; 1999 Feb; 13(2):349-55. PubMed ID: 10065680
[TBL] [Abstract][Full Text] [Related]
45. Validation and incidence of community-acquired pneumonia in patients with type 2 diabetes in the BIFAP database.
Saiz LC; Garjón J; Gorricho J; Erviti J; Gil-García MJ; Martín-Merino E
Epidemiol Infect; 2017 Oct; 145(14):3056-3064. PubMed ID: 28854991
[TBL] [Abstract][Full Text] [Related]
46. Aetiology of, and risk factors for, recurrent community-acquired pneumonia.
Garcia-Vidal C; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F
Clin Microbiol Infect; 2009 Nov; 15(11):1033-8. PubMed ID: 19673961
[TBL] [Abstract][Full Text] [Related]
47. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
48. Short-term mortality of adult inpatients with community-acquired pneumonia: external validation of a modified CURB-65 score.
Pflug MA; Tiutan T; Wesemann T; Nüllmann H; Heppner HJ; Pientka L; Thiem U
Postgrad Med J; 2015 Feb; 91(1072):77-82. PubMed ID: 25618316
[TBL] [Abstract][Full Text] [Related]
49. Optimal treatment strategies for community-acquired pneumonia: high-risk patients (geriatric and with comorbidity).
Carbon C
Chemotherapy; 2001; 47 Suppl 4():19-25; discussion 26-7. PubMed ID: 11586002
[TBL] [Abstract][Full Text] [Related]
50. [Study on epidemic characteristics and etiology of community acquired pneumonia in Guangzhou from 2009 to 2012].
Liu H; Xiao XC; Lu JY; Chen ZQ; Luo L; Yang ZC
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Dec; 47(12):1089-94. PubMed ID: 24529265
[TBL] [Abstract][Full Text] [Related]
51. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.
Corrales-Medina VF; Musher DM; Wells GA; Chirinos JA; Chen L; Fine MJ
Circulation; 2012 Feb; 125(6):773-81. PubMed ID: 22219349
[TBL] [Abstract][Full Text] [Related]
52. Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults.
Suaya JA; Jiang Q; Scott DA; Gruber WC; Webber C; Schmoele-Thoma B; Hall-Murray CK; Jodar L; Isturiz RE
Vaccine; 2018 Mar; 36(11):1477-1483. PubMed ID: 29429807
[TBL] [Abstract][Full Text] [Related]
53. [Community-acquired pneumonia based on the Turkish national data].
Ozlü T; Bülbül Y; Ozsu S
Tuberk Toraks; 2007; 55(2):191-212. PubMed ID: 17602349
[TBL] [Abstract][Full Text] [Related]
54. High Lung Cancer Incidence in Heavy Smokers Following Hospitalization due to Pneumonia.
Shepshelovich D; Goldvaser H; Edel Y; Shochat T; Lahav M
Am J Med; 2016 Mar; 129(3):332-8. PubMed ID: 26551976
[TBL] [Abstract][Full Text] [Related]
55. Hospitalisation with community-acquired pneumonia among patients with type 2 diabetes: an observational population-based study in Spain from 2004 to 2013.
López-de-Andrés A; de Miguel-Díez J; Jiménez-Trujillo I; Hernández-Barrera V; de Miguel-Yanes JM; Méndez-Bailón M; Pérez-Farinós N; Salinero-Fort MÁ; Jiménez-García R
BMJ Open; 2017 Jan; 7(1):e013097. PubMed ID: 28057653
[TBL] [Abstract][Full Text] [Related]
56. Gender differences in community-acquired pneumonia.
Barbagelata E; Cillóniz C; Dominedò C; Torres A; Nicolini A; Solidoro P
Minerva Med; 2020 Apr; 111(2):153-165. PubMed ID: 32166931
[TBL] [Abstract][Full Text] [Related]
57. Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors.
von Baum H; Welte T; Marre R; Suttorp N; Ewig S;
Eur Respir J; 2010 Mar; 35(3):598-605. PubMed ID: 19679601
[TBL] [Abstract][Full Text] [Related]
58. The relationship between nicotine dependence level and community-acquired pneumonia in young soldiers: a case control study.
Tas D; Sevketbeyoglu H; Aydin AF; Celik K; Karaca MA
Intern Med; 2008; 47(24):2117-20. PubMed ID: 19075535
[TBL] [Abstract][Full Text] [Related]
59. Systematic review on the etiology and antibiotic treatment of pneumonia in human immunodeficiency virus-infected children.
Punpanich W; Groome M; Muhe L; Qazi SA; Madhi SA
Pediatr Infect Dis J; 2011 Oct; 30(10):e192-202. PubMed ID: 21857264
[TBL] [Abstract][Full Text] [Related]
60. Outcomes in females hospitalised with community-acquired pneumonia are worse than in males.
Arnold FW; Wiemken TL; Peyrani P; Mirsaeidi M; Ramirez JA;
Eur Respir J; 2013 May; 41(5):1135-40. PubMed ID: 22835618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
